Skip to content

Author

Shadi Farsaei

We have 3 of 52 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Drug-Related Problems and Clinical Pharmacist Interventions in Intensive Care Unit Patients: A Cross-Sectional Study

Background: Drug-related problems (DRPs) are highly prevalent among critically ill patients in intensive care units (ICUs) and may negatively influence clinical outcomes. Pharmacist-led interventions play a pivotal role in detecting and resolving DRPs; however, their implementation and acceptance vary across healthcare...

Sarah Mousavi, Monireh Karimi, S. Farsaei · 0 citations
Open access Aug 2026

Rational Use of Tocilizumab in Critically Ill COVID-19 Patients: A Two-Center Observational Study in the Intensive Care Unit

Background: Tocilizumab (TCZ) is a key treatment for severe COVID-19 but poses risks due to immunosuppression and limited evidence. Concerns about misuse and limited supply necessitate a thorough assessment. This study investigates the utilization patterns and appropriateness of tocilizumab use in critically ill COVID-...

Atefeh Afzali, Shadi Farsaei, R. Soltani · 0 citations
Jul 2026

Fabrication and Characterization of Bilayer Electrospun Polyvinyl alcohol/Polycaprolactone/Glutamine Membranes Integrated with 3D-Printed Polycaprolactone/Propolis Scaffolds for Skin Tissue Applications

The PCL/PRP–PVA/PCL/GLT (4% w/v) bilayer scaffold shows promising physicochemical and biological performance for wound healing applications.

Fatemeh Azimi Gharibdosti, M. Mehdikhani, Melika Babaei et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.